Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: Oxidative consequences?

Annals of the New York Academy of Sciences

Volumn 844, Issue , 1998, Pages 103-107

  Hansom, Glen R ^a   Gibb, James W ^a   Metzger, Ryan R ^a   Kokoshka, Jerry M ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; ENZYME ACTIVITY; EXTRAPYRAMIDAL SYSTEM; MONOAMINERGIC SYSTEM; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PROTEIN MODIFICATION; RAT;

ANIMALIA;

EID: 0031868646     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb08225.x     Document Type: Conference Paper

References (23)

1. U.S. Department of Justice. March, 1996. Methamphetamine situation in the United States. Drug Enforcement Administration publication, DEA-96012.
2. HOTCHKISS, A. & J.W. GIBB. 1980. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase in rat brain. J. Pharmacol. Exp. Ther. 214: 257-262.
3. SONSALLA, P.K., J.W. GIBB & G.R. HANSON. 1986. Roles of D-l and D-2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J. Pharmacol. Exp. Ther. 238: 932-937.
4. WOOLVERTON, W.L., G.A. RICAURTE, L.S. FORNO & L.S. SEIDEN. 1989. Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res. 486: 73-78.
5. RYAN, L.J., J.C. LINDER, M.E. MARTONE & P.M. GROVES. 1990. Histological and ultrastructural evidence that d-methamphetamine causes degeneration in neostriatum and frontal cortex of rats. Brain Res. 518: 67-77.
6. WAGNER, G.C., G. RICAURTE, L. SEIDEN, C.R. SCHUSTER, R.J. MILLER & J. WESTLEY. 1980. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181: 151-158.
7. JOHNSON, M., D.M. STONE, G.R. HANSON & J.W, GIBB. 1987. Roles of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic systems. Eur. J. Pharmacol. 135: 231-234.
8. SCHMIDT, C.J., J.K., RITTER, P.K. SONSALLA, G.R. HANSON & J.W. GIBB. 1985. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233: 539-544.
9. FILLIOUX, F. & J. TOWNSEND. 1993. Pre- and post-synaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp. Neurol. 199: 79-88.
10. MICHAEL, P. & F. HEFTI. 1990. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26: 428-435.
11. HALLIWELL, B. 1992. Reactive oxygen species and the central nervous system J. Neurochem. 59: 1609-11623.
12. FLECKENSTEIN, A.E., D.O. WILKINS, J.W. GIBB & G.R. HANSON. 1997. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmacol. Exp. Then 283: 281-285.
13. GIOVANNI, A., L. LIANG, T. HASTINGS & M.J. ZIGMOND. 1995. Estimating hydroxy radical content in rat brain using systemic and intraventricular salicylate: Impact of methamphetamine. J. Neurochem. 64: 1819-1825.
14. KUHN, D.M., B. RUSKIN & W. LOVENBERG. 1980. Tryptophan hydroxylase: The role of oxygen, iron, and sulfhydryl groups as determinants of stability and catalytic activity. J. Biol. Chem. 255: 4137-4143.
15. BAKHIT, C. & J.W. GIBB. 1981. Methamphetamine-induced depression of tryptophan hydroxylase: Recovery following acute treatment. Eur. J. Pharmacol. 76: 229-233.
16. HOTCHKISS, A. & J.W. GIBB. 1980. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214: 257-262.
17. AXT, K.J., L. MAMOUNAS & M.E. MOLLIVER. 1994. Structural features of amphetamine neurotoxicity in the brain. In Amphetamine and Its Analogs. A. Cho & D. Segal, Eds.: 315-367. Academic Press. San Diego, CA.
18. STONE, D.M., M. JOHNSON, G.R. HANSON & J.W. GIBB. 1989. Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites. Eur. J. Pharmacol. 172: 93-97.
19. JOHNSON, M., D.M. STONE, G.R. HANSON & J.W. GIBB. 1987. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur. J. Pharmacol. 135: 231-234.
20. BERMAN, S.B., M.J. ZIGMOND & T. HASTINGS. 1996. Modification of dopamine transporter function: Effect of reactive oxygen species and dopamine. J. Neurochem. 67: 593-600.
21. METZGER, R.R., A.E. FLECKENSTEIN, M.E. BEYELER, J.W. GIBB & G.R. HANSON. 1996. Effects of reactive oxygen species on dopamine transporter function in rat striatum: Implications for methamphetamine toxicity. Soc. Neurosci. Abstr. 815.5.
22. EDVARDSEN, E. & S. DAHL. 1994. A putative model of the dopamine transporter. Mol. Brain Res. 27: 265-274.
23. FLECKENSTEIN, A.E., R.R. METZGER, D.G. WILKINS, J.W. GIBB & G.R. HANSON. 1997. Rapid and reversible effects of mehtamphetamine on dopamine transporters. J. Pharmacol. Exp. Ther. 282: 834-838.